Dr Mastroyannis on the Administration and Utility of HIPEC in Ovarian Cancer
September 27th 2023S. Alex Mastroyannis, MD, MSCE, discusses the administration and role of hyperthermic intraperitoneal chemotherapy in ovarian cancer, as well as its benefit for patients in the phase 3 OVHIPEC-1 trial.
Read More